Divalproex Sodium Tablet, Delayed Release
Product Images NDC 71335-2885

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 71335-2885). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (674e58bd F580 4805 A7e2 Febcaa37bca5 01)

FDA Label Image

Image (674e58bd F580 4805 A7e2 Febcaa37bca5 02)

FDA Label Image

Image (674e58bd F580 4805 A7e2 Febcaa37bca5 03)

FDA Label Image

Image (674e58bd F580 4805 A7e2 Febcaa37bca5 04)

FDA Label Image

Image (674e58bd F580 4805 A7e2 Febcaa37bca5 05)

Not available.*

FDA Label Image

Image (674e58bd F580 4805 A7e2 Febcaa37bca5 1830 2)

FDA Label Image

Label (Lbl713352885)

This is the packaging information for a medication containing Divalproex Sodium equivalent to Valproic acid. Each enteric-coated delayed-release tablet contains 250 mg of Valproic acid activity. The tablets should be stored at 20° to 25°C. Pharmacists are required to dispense the medication guide to each patient. The medication is manufactured by Unichem Laboratories Ltd and distributed by Bryant Ranch Prepack, Inc. It should be dispensed in a tight, light-resistant container as per USP guidelines.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.